KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Encompass Health (EHC) over the last 16 years, with Q4 2024 value amounting to $577.9 million.

  • Encompass Health's Treasury Shares rose 561.04% to $577.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $577.9 million, marking a year-over-year increase of 561.04%. This contributed to the annual value of $577.9 million for FY2024, which is 561.04% up from last year.
  • Encompass Health's Treasury Shares amounted to $800000.0 in Q3 2025, which was up 16666.67% from $600000.0 recorded in Q2 2025.
  • Encompass Health's 5-year Treasury Shares high stood at $15.3 million for Q4 2024, and its period low was $200000.0 during Q2 2024.
  • In the last 3 years, Encompass Health's Treasury Shares had a median value of $600000.0 in 2025 and averaged $4.7 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 103.6% in 2020, then skyrocketed by 561.04% in 2024.
  • Over the past 5 years, Encompass Health's Treasury Shares (Quarter) stood at $497.4 million in 2020, then grew by 4.78% to $521.2 million in 2021, then grew by 2.97% to $536.7 million in 2022, then increased by 1.96% to $547.2 million in 2023, then rose by 5.61% to $577.9 million in 2024.
  • Its Treasury Shares was $577.9 million in Q4 2024, compared to $547.2 million in Q4 2023 and $536.7 million in Q4 2022.